Home » Clinical Trials » Search Clinical Trials Therapeutic Areas: Ophthalmology | Genetic Disease
Macular Degeneration Clinical Trials
A listing of Macular Degeneration medical research trials actively recruiting patient volunteers. Use the filters below to narrow your search results.
Filter by:
Phase:
All
N/A
0
1
1/2
2
2/3
3
4
Gender:
Both
Male
Female
Age:
Location:
All
US: Alabama
US: Alaska
US: Arizona
US: Arkansas
US: California
US: Colorado
US: Connecticut
US: Delaware
US: District of Columbia
US: Florida
US: Georgia
US: Hawaii
US: Idaho
US: Illinois
US: Indiana
US: Iowa
US: Kansas
US: Kentucky
US: Louisiana
US: Maine
US: Maryland
US: Massachusetts
US: Michigan
US: Minnesota
US: Mississippi
US: Missouri
US: Montana
US: Nebraska
US: Nevada
US: New Hampshire
US: New Jersey
US: New Mexico
US: New York
US: North Carolina
US: North Dakota
US: Ohio
US: Oklahoma
US: Oregon
US: Pennsylvania
US: Rhode Island
US: South Carolina
US: South Dakota
US: Tennessee
US: Texas
US: Utah
US: Vermont
US: Virgin Islands
US: Virginia
US: Washington
US: West Virginia
US: Wisconsin
US: Wyoming
Afghanistan
Åland Islands
Albania
Algeria
American Samoa
Andorra
Angola
Anguilla
Antarctica
Antigua and Barbuda
Argentina
Armenia
Aruba
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bermuda
Bhutan
Bolivia
Bosnia and Herzegovina
Botswana
Bouvet Island
Brazil
British Indian Ocean Territory
Brunei Darussalam
Bulgaria
Burkina Faso
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Cayman Islands
Central African Republic
Chad
Chile
China
Christmas Island
Cocos (Keeling) Islands
Colombia
Comoros
Congo
Congo, The Democratic Republic of the
Cook Islands
Costa Rica
Côte D'ivoire
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Falkland Islands (Malvinas)
Faroe Islands
Fiji
Finland
France
French Guiana
French Polynesia
French Southern Territories
Gabon
Gambia
Georgia
Germany
Ghana
Gibraltar
Greece
Greenland
Grenada
Guadeloupe
Guam
Guatemala
Guernsey
Guinea
Guinea-Bissau
Guyana
Haiti
Heard Island And Mcdonald Islands
Holy See (Vatican City State)
Honduras
Hong Kong
Hungary
Iceland
India
Indonesia
Iran, Islamic Republic of
Iraq
Ireland
Isle Of Man
Israel
Italy
Jamaica
Japan
Jersey
Jordan
Kazakhstan
Kenya
Kiribati
Korea, Democratic People's Republic of
Korea, Republic of
Kuwait
Kyrgyzstan
Lao People's Democratic Republic
Latvia
Lebanon
Lesotho
Liberia
Libyan Arab Jamahiriya
Liechtenstein
Lithuania
Luxembourg
Macao
Macedonia, The Former Yugoslav Republic of
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Martinique
Mauritania
Mauritius
Mayotte
Mexico
Micronesia, Federated States of
Moldova, Republic of
Monaco
Mongolia
Montenegro
Montserrat
Morocco
Mozambique
Myanmar
Namibia
Nauru
Nepal
Netherlands
Netherlands Antilles
New Caledonia
New Zealand
Nicaragua
Niger
Nigeria
Niue
Norfolk Island
Northern Mariana Islands
Norway
Oman
Pakistan
Palau
Palestinian Territory, Occupied
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Pitcairn
Poland
Portugal
Puerto Rico
Qatar
Réunion
Romania
Russian Federation
Rwanda
Saint Barthélemy
Saint Helena
Saint Kitts And Nevis
Saint Lucia
Saint Martin
Saint Pierre and Miquelon
Saint Vincent and The Grenadines
Samoa
San Marino
Sao Tome And Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Georgia and the South Sandwich Islands
Spain
Sri Lanka
Sudan
Suriname
Svalbard And Jan Mayen
Swaziland
Sweden
Switzerland
Syrian Arab Republic
Taiwan, Province of China
Tajikistan
Tanzania, United Republic of
Thailand
Timor-Leste
Togo
Tokelau
Tonga
Trinidad And Tobago
Tunisia
Turkey
Turkmenistan
Turks And Caicos Islands
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
United States Minor Outlying Islands
Uruguay
Uzbekistan
Vanuatu
Venezuela
Viet Nam
Virgin Islands, British
Virgin Islands, U.S.
Wallis And Futuna
Western Sahara
Yemen
Zambia
Zimbabwe
First 1 2 3 4 5 6 7 Last
Arizona
Retina Consultants of Arizona
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
Phoenix Arizona
A clinical research study of ACU-4429 and Placebo for the treatment of Geographic Atrophy
Phoenix Arizona
A clinical trial seeking patients for a research study for the treatment of Age-related Macular Degeneration
Associated Retina Consultants
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
Retina Consultants of Arizona
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
View More »
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
Novartis Investigative Site
Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration
Novartis Investigative Site
A clinical research study of LFG316 and Placebo for the treatment of Neovascular Age-elated Macular Degeneration (Wet AMD) or Exudative Macular Degeneration
Retina Associates SW
A clinical research study of Squalamine lactate and Vehicle control for the treatment of Neovascular Age Related Macular Degeneration
Retina Centers, P.C.
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
Pfizer Investigational Site
Updated
A clinical trial to evaluate treatments using RN6G and Placebo for patients with Age-Related Maculopathy
Tucson Arizona 85710
A Phase 3 clinical study for patients with Age-Related Macular Degeneration
California
Pfizer Investigational Site
Updated
A clinical trial to evaluate treatments using RN6G and Placebo for patients with Age-Related Maculopathy
Arcadia California Updated
A Phase 1 clinical study for patients with Age-related Macular Degeneration
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
California Retina Consultants
A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration
California Retinal Consultants
A clinical research study of Squalamine lactate and Vehicle control for the treatment of Neovascular Age Related Macular Degeneration
View More »
Retina-Vitreous Associates
A clinical research study of Squalamine lactate and Vehicle control for the treatment of Neovascular Age Related Macular Degeneration
Retina-Vitreous Associates Medical Group
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
Novartis Investigative Site
Patients are needed to participate in a clinical research study of LFG316 and Sham to evaluate Geographic Atrophy or Age-related Macular Degeneration
Retina Vitreous Associates Medical Group
Patients are needed to participate in a clinical research study of X-82 oral and ranibizumab (Lucentis) to evaluate Exudative Macular Degeneration
Retinal Diagnostic Center
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
Morris Eye Group
A clinical trial to evaluate treatments for patients with Age-related Macular Degeneration or Choroidal Neovascular Age-related Macular Degeneration
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
Shiley Eye Center, UCSD
A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
Retina Associates of Orange County
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
Jules Stein Eye Institute/UCLA
A clinical research study of Microplasmin and Placebo control for the treatment of Macular Degeneration
Jules Stein Eye Institute, UCLA School of Medicine
A clinical trial seeking patients for a research study for the treatment of Dry Age Related Macular Degeneration
Jules Stein Eye Institute, UCLA School of Medicine
A clinical trial to evaluate treatments using MA09-hRPE Cellular therapy for patients with Stargardt's Macular Dystrophy
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
Marietta Eye Clinic
A clinical trial to evaluate treatments using pegaptanib sodium injection for patients with Age-Related Macular Degeneration, Retinal Vein Occlusion or Diabetic Macular Edema
Northern California Retina Vitreous Associates
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
Pfizer Investigational Site
Updated
A clinical trial to evaluate treatments using RN6G and Placebo for patients with Age-Related Maculopathy
Byers Eye Institute at Stanford, Stanford Hospital and Clinics
A clinical research study of HuCNS-SC cells for the treatment of Age Related Macular Degeneration, Macular Degeneration or AMD
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
Retinal Consultants Medical Group, Inc.
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
Sacramento California 95819
A Phase 3 clinical study for patients with Age-Related Macular Degeneration
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
Pacific Eye Associates
Patients are needed to participate in a clinical research study evaluating RetnaGene AMD LDT for the treatment of Age-related Macular Degeneration
Orange County Retina Medical Group
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
California Retina Consultants
A clinical research study of ranibizumab for the treatment of Age-Related Macular Degeneration
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
Miramar Eye Specialists
A clinical trial to evaluate treatments using iSONEP, 0.5 mg iSONEP & Lucentis/Avastin/Eylea, 4.0 mg iSONEP & Lucentis/Avastin/Eylea and ranibizumab or bevacizumab or aflibercept for patients with Exudative Age-related Macular Degeneration
Colorado
Colorado Retina
A clinical research study of Squalamine lactate and Vehicle control for the treatment of Neovascular Age Related Macular Degeneration
GSK Investigational Site
A Phase 2 clinical study for patients with Atrophy, Geographic
Connecticut
New England Retina Associates
Patients are needed to participate in a clinical research study of X-82 oral and ranibizumab (Lucentis) to evaluate Exudative Macular Degeneration
Florida
Pfizer Investigational Site
Updated
A clinical trial to evaluate treatments using RN6G and Placebo for patients with Age-Related Maculopathy
Pfizer Investigational Site
Updated
A clinical trial to evaluate treatments using RN6G and Placebo for patients with Age-Related Maculopathy
First 1 2 3 4 5 6 7 Last
